In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to emerge in late responders.

The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...

More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...

More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.

Find out how vagus nerve stimulation delivers durable symptom relief and quality of life gains in treatment resistant depression patients.

While proven a safe method, external trigeminal nerve stimulation was nonsuperior to sham treatment as early as 4 weeks and as long as 6 months in children and adolescents with ADHD, according to data ...

Researchers report that vagus nerve stimulation helped many people with long-standing, treatment-resistant depression feel ...

A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.

TNS seems safe, with no serious adverse events, but no significant differential treatment effects seen versus sham TNS ...

CMOS technology has become a fundamental enabler in the advancement of neural stimulation devices, combining the benefits of low-power operation with high-density integration, thus allowing for ...

Discover how groundbreaking insights into thalamic connectivity are reshaping treatment approaches for essential tremor, paving the way for personalized and more effective DBS therapies. Study: ...